Reduction of paclitaxel-induced peripheral neuropathy with glutamine.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Cancer Research

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 11350883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compartmentation of brain glutamate metabolism in neurons and glia.

  2000cited by this paper
• Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.

  2000cited by this paper
• Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.

  1999cited by this paper
• Inhibition of Glutamine Transport in Rat Brain Mitochondria by Some Amino Acids and Tricarboxylic Acid Cycle Intermediates

  1999cited by this paper
• Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias.

  1999cited by this paper
• Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel.

  1999cited by this paper
• Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer.

  1999cited by this paper
• Effect of glutamine on methotrexate efficacy and toxicity.

  1998cited by this paper
• Clinical trials for polyneuropathy: the role of nerve conduction studies, quantitative sensory testing, and autonomic function testing.

  1998cited by this paper
• Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

  1998cited by this paper
• Glutamine treatment of paclitaxel-induced myalgias and arthralgias.

  1998influential reference
• Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.

  1998cited by this paper
• Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

  1997cited by this paper
• Harvest Quality and Factors Affecting Collection and Engraftment of CD34+ Cells in Patients with Breast Cancer Scheduled for High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Support

  1997cited by this paper
• Endogenous glutamate levels regulate nerve growth factor mRNA expression in the rat dentate gyrus.

  1997cited by this paper
• Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.

  1996cited by this paper
• Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy.

  1996cited by this paper
• Glutamine, cancer, and its therapy*

  1996cited by this paper
• Quantitative sensory testing (QST)

  1996cited by this paper
• Quantitative sensory testing (QST)

  1996cited by this paper
• Effect of glutamine supplementation on protein metabolism and glutathione in tumor-bearing rats.

  1995cited by this paper
• Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

  1995cited by this paper
• Concept of true and perceived placebo effects

  1995cited by this paper
• Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue.

  1995cited by this paper
• 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation.

  1994cited by this paper
• Clinical toxicities encountered with paclitaxel (Taxol).

  1993cited by this paper
• Quantitative sensory testing

  1993cited by this paper
• Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association.

  1993cited by this paper
• Large and small fibre type sensory dysfunction in patients with cancer.

  1991cited by this paper
• Glutamine nutrition and requirements.

  1990cited by this paper
• Reduction of tumor growth following treatment with a glutamine antimetabolite.

  1988cited by this paper
• Vibratory and Cooling Detection Thresholds Compared With Other Tests in Diagnosing and Staging Diabetic Neuropathy

  1987cited by this paper
• Principles of Neural Science

  1981cited by this paper
• Br. J. Cancer '."

  year unknowncited by this paper

• Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

  2024cites this paper
• Effects of essential amino acid (EAA) and glutamine supplementation on skeletal muscle wasting in acute, subacute, and postacute conditions.

  2024cites this paper
• Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review

  2023cites this paper
• Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol

  2023cites this paper
• Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221

  2023cites this paper
• Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis

  2022cites this paper
• Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

  2021cites this paper
• Evidence-based recommendations for the management of symptoms and care for patients with multiple myeloma

  2020cites this paper
• Neurologic Complications

  2020cites this paper
• Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study

  2020cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2020cites this paper
• Relief of eribulin-associated malaise by l-glutamine in two patients with uterine leiomyosarcoma: a case report

  2020cites this paper
• Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study

  2020cites this paper
• Complementary and Alternative Medicine

  2020cites this paper
• Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Advances in Pharmacology and Clinical Trials

  2019cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2019cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2019cites this paper
• Targeting strategies for chemotherapy-induced peripheral neuropathy: does gut microbiota play a role?

  2019cites this paper
• Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer

  2019cites this paper
• Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

  2018influential citation
• 6 Peripheral Neuropathy in Ovarian Cancer

  2018cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2018cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2018cites this paper
• Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy

  2018cites this paper
• Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy

  2017cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2017cites this paper
• The Possible Role of Propolis in Ameliorating Paclitaxel-Induced Peripheral Neuropathy in Sciatic Nerve of Adult Male Albino Rats

  2017cites this paper
• Nutritional Modulators in Chemotherapy-Induced Neuropathic Pain

  2017cites this paper
• Disease and Symptom Care: A Focus on Specific Needs of Patients With Multiple Myeloma
.

  2017cites this paper
• Renal, GI, and Peripheral Nerves: Evidence‐based recommendations for the management of symptoms and care for patients with multiple myeloma

  2017cites this paper
• Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer

  2017cites this paper
• Chemotherapy‐induced neuropathies—a growing problem for patients and health care providers

  2016cites this paper
• A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy

  2016cites this paper
• The Interaction of Iron with Proteins and Sugars in Biological Fluids and Beverages

  2016cites this paper
• Screening to Identify Multidrug Resistance-Associated Protein Inhibitors with Neuroblastoma-Selective Cytotoxicity.

  2016cites this paper
• New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy

  2016influential citation
• A Systematic Review on Neuropathy

  2016cites this paper
• N(2)-L-Alanyl-L-Glutamine Dipeptide Preventing Oxaliplatin-Induced Neurotoxicity in Colorectal Cancer Patients

  2016cites this paper
• Taxane induced neuropathy in patients affected by breast cancer: Literature review.

  2015cites this paper
• Right Place, Right Time: Preferences of Women with Ovarian Cancer for Delivery of CAM Education

  2015cites this paper
• Relationship between pre-treatment nutritional status, serum glutamine, arginine levels and clinicopathological features in Taiwan colorectal cancer patients.

  2015cites this paper
• Intravenous glutamine appears to reduce the severity of symptomatic platinum-induced neuropathy: a prospective randomized study

  2015cites this paper
• Biobehavioral approaches to pain

  2014cites this paper
• Chemotherapy-induced neuropathy: A comprehensive survey.

  2014cites this paper
• Occupational exposure to municipal solid wastes and development of toxic neuropathies: Possible role of nutrient supplementation, complementary and alternative medicines in chemoprevention

  2014cites this paper
• The Use of Dietary Supplements in Oncology

  2014cites this paper
• Glutamine-Enriched Total Parenteral Nutrition and Glutamine Supplementation in Gastrointestinal Cancer Patients

  2014cites this paper
• Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy

  2014cites this paper
• Advances in the Management of Oxaliplatin-Induced Neuropathy: Focus on Glutamine and Using Pharmacogenomics to Predict the Effectiveness of Opioid Drugs

  2014cites this paper
• Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.

  2014cites this paper
• Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.

  2013cites this paper
• Persistent pain after breast cancer treatment.

  2013cites this paper
• Successful Treatment by Adding Duloxetine to Pregabalin for Peripheral Neuropathy Induced by Paclitaxel

  2013cites this paper
• Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Lung Cancer Treatment

  2013cites this paper
• Nutrition in oncologic patients during antiblastic treatment.

  2013cites this paper
• Integrating Dietary Supplements Into Cancer Care

  2013cites this paper
• Pharmacogenetic predictors of taxane-induced peripheral neuropathy

  2013cites this paper
• Effect of l-glutamine on myenteric neuron and of the mucous of the ileum of diabetic rats.

  2013cites this paper
• Chemotherapy‐Induced Neuropathic Pain and Its Relation to Cluster Symptoms in Breast Cancer Patients Treated with Paclitaxel

  2013cites this paper
• Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.

  2013cites this paper
• Chemotherapy-induced neuropathy: prevention and treatment

  2012cites this paper
• Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.

  2012cites this paper
• Clinical trials in integrative therapies.

  2012cites this paper
• Neurotoxic Complications of Chemotherapy in Patients with Cancer

  2012cites this paper
• Neuropathy Secondary to Chemotherapy: A Real Issue for Cancer Survivors

  2012cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2012cites this paper
• Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

  2012cites this paper
• Etodolac, a Cyclooxygenase-2 Inhibitor, Attenuates Paclitaxel-Induced Peripheral Neuropathy in a Mouse Model of Mechanical Allodynia

  2012cites this paper
• Chemotherapy-induced peripheral neuropathy. Part II. Prevention

  2012cites this paper
• Obwodowa neuropatia wywołana chemioterapią. Część II. Zapobieganie

  2012cites this paper
• Neurological complications of chemotherapy to the peripheral nervous system.

  2012cites this paper
• Peripheral Neuropathy in Ovarian Cancer

  2012cites this paper
• Nonpharmacologic complementary therapies in symptom management for breast cancer survivors.

  2011cites this paper
• Chemotherapy‐Induced Peripheral Neuropathy: Prevention and Treatment

  2011cites this paper
• Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach.

  2011cites this paper
• A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

  2011cites this paper
• Nutritional challenges during treatment for lung cancer.

  2011cites this paper
• Perspectivas terapêuticas na prevenção da neuropati periférica induzida por quimioterápicos ( NPIQ ) Therapeutic perspectives in the prevention of chemotherapy-induced peripheral neuropathy ( CIPN )

  2011cites this paper
• Effect of anionic micelles on speciation of L-glutamine in presence/absence of metals

  2011cites this paper
• Chemotherapy-induced peripheral neuropathy: a literature review.

  2011cites this paper
• The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

  2011cites this paper
• Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma: Principles of Identification and Management

  2011cites this paper
• Symptoms and Late Effects of Cancer Therapy in Breast Cancer Survivors Fatigue Hot flashes Insomnia Neuropathy Sexual dysfunction

  2011cites this paper
• Neuropatía inducida por el tratamiento médico del cáncer

  2010cites this paper
• Efeitos da Glutamina no Câncer Colorretal Evidências da Literatura

  2010cites this paper
• Glutamine as indispensable nutrient in oncology: experimental and clinical evidence

  2010cites this paper
• Neuropatía inducida por quimioterapia: un problema no resuelto

  2010cites this paper
• Chemotherapie-induzierte Polyneuropathie (CIPN): Ein progredientes Problem im onkologischen Alltag

  2010cites this paper
• A Trial to Assess the Efficacy of Glutamic Acid in Prevention of Vincristine-induced Neurotoxicity in Pediatric Malignancies: A Pilot Study

  2010cites this paper
• [Chemotherapy-induced peripheral neuropathy: an unresolved issue].

  2010cites this paper
• Neuromuscular Disease and Spinal Cord Compression

  2010cites this paper
• Ensemble de substances comprenant de la l-glutamine et de la egcg

  2010cites this paper
• The Present Clinical Studies of Oriental Medicine and CAM Therapies in Chemotherapy-induced Peripheral Neurotoxicity

  2009cites this paper
• Management of peripheral neuropathy caused by microtubule inhibitors.

  2009influential citation
• Utilisation et place des compléments nutritionnels oraux pour les malades cancéreux

  2009cites this paper
• Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.

  2009cites this paper
• Nitric Oxide Deficiency / Impaired Endothelial Function : The Arginine Connection

  2009cites this paper
• Integrative healthcare symposium: cancer and chronic lyme disease.

  2009cites this paper
• Dichotomic actions of glutamine in host versus tumour: an emerging concept

  2009cites this paper